Viral Vector and Plasmid DNA Testing Services Market to hit US$ 1,966.46 million by 2033 | Most Leading Companies - PathoQuest, Coriolis Pharma, Lonza, AGC Biologics, Exothera, Batavia Biosciences B.V. and ReiThera srl

viral vector and plasmid DNA testing services market reached US$ 228.83 million in 2023, with a rise of US$ 291.13 million in 2024, and is expected to reach US$ 1,966.46 million by 2033, growing at a CAGR of 23.2% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Viral Vector and Plasmid DNA Testing Services Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/viral-vector-and-plasmid-dna-testing-services-market?kb

Key Players:

Charles River Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, PathoQuest, Coriolis Pharma, Lonza, AGC Biologics, Exothera, Batavia Biosciences B.V. and ReiThera srl

Key Development:

✅ August 2025 - ProBio launched cGMP AAV manufacturing services at its 128,000 sq. ft. Hopewell, NJ facility, integrating plasmid DNA and viral vector production. This expansion meets growing demand for high-quality gene therapies, accelerates development timelines, and reinforces ProBio's commitment to delivering transformative treatments efficiently.

✅ August 2025 - Bionova Scientific, a biologics CDMO and subsidiary of Japan's Asahi Kasei, opened a 10,000 sq. ft. plasmid DNA (pDNA) facility in The Woodlands, Texas. This expansion complements its antibody and protein CDMO services and strengthens support for mRNA and viral vector-based cell and gene therapies, enhancing its biotherapeutic portfolio.

✅ June 2024 - Charles River Laboratories partnered with the Gates Institute at the University of Colorado Anschutz Medical Campus under a CDMO agreement to develop GMP-grade lentiviral vectors (LVVs). These vectors will advance novel CAR T-cell therapies for hematological cancers, leveraging Charles River's expertise in cell and gene therapy manufacturing.

Growth Forecast Projected:

The Global Viral Vector and Plasmid DNA Testing Services Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Viral Vector and Plasmid DNA Testing Services Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=viral-vector-and-plasmid-dna-testing-services-market

Key Segments:

Viral vector testing leads with 39.2% market share

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Viral Vector and Plasmid DNA Testing Services producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Viral Vector and Plasmid DNA Testing Services revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/viral-vector-and-plasmid-dna-testing-services-market?kb

FAQ's

Q1: What is the current size of the Viral Vector and Plasmid DNA Testing Services Market?

A: The Viral Vector and Plasmid DNA Testing Services Market stood at US$ 228.83 million in 2023 and is set to experience remarkable growth, reaching US$ 291.13 million in 2024

Q2: How fast is the Viral Vector and Plasmid DNA Testing Services Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 23.2% from 2025 to 2032

Q3: Which regions are dominating the Viral Vector and Plasmid DNA Testing Services Market and which are fastest-growing?

A: North America holds 40.2% of viral vector testing market

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/viral-vector-and-plasmid-dna-testing-services-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.